Citadel Advisors’s MedAvail Holdings, Inc. Common Stock MDVL Stock Holding History

Citadel Advisors’s Portfolio MDVL Stock Details MDVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-403	Closed	-$23.1K	–	13907
2022 Q2	$31K	Buy	+403	New	+$35.4K	﹤0.01%	12213
2022 Q1	–	Sell	-597	Closed	-$42K	–	14876
2021 Q4	$42K	Buy	+597	New	+$64.3K	﹤0.01%	13350
2020 Q1	–	Sell	-61	Closed	-$44K	–	10360
2019 Q4	$44K	Buy	+61	New	+$51.9K	﹤0.01%	8790
2019 Q2	–	Sell	-35	Closed	-$33K	–	10033
2019 Q1	$33K	Sell	35 -13	-27%	-$12.4K	﹤0.01%	8969
2018 Q4	$40K	Buy	48 +26	+118%	+$19.7K	﹤0.01%	8541
2018 Q3	$16K	Sell	22 -21	-49%	-$16.6K	﹤0.01%	9055
2018 Q2	$38K	Buy	+43	New	+$36.5K	﹤0.01%	8495
2018 Q1	–	Sell	-23	Closed	-$19K	–	8927
2017 Q4	$19K	Buy	+23	New	+$18.6K	﹤0.01%	7838
2016 Q4	–	Sell	-26	Closed	-$26K	–	7998
2016 Q3	$26K	Buy	26 +9	+53%	+$9.62K	﹤0.01%	6986
2016 Q2	$20K	Buy	+17	New	+$18.8K	﹤0.01%	6610
2016 Q1	–	Sell	-18	Closed	-$20K	–	8232
2015 Q4	$20K	Buy	+18	New	+$26.6K	﹤0.01%	7931

Other funds holding MDVL

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

AWGLSCP

ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $12.3M AUM 3.13% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

ABG

Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return

Cigna Investments Bloomfield, Connecticut $773M AUM 44.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors's MDVL Position: Q3 2022 in Review

Citadel Advisors sold out of MedAvail Holdings, Inc. Common Stock (MDVL) in Q3 2022, closing a stake of 403 shares — an estimated $23.1K sold.

Citadel Advisors first reported a position in MDVL in Q4 2015 and held it in 11 quarters. The position peaked at $44K in Q4 2019. 32 funds tracked by Wall St. Rank hold MDVL as of Q3 2022.

Citadel Advisors reported no remaining MedAvail Holdings, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Citadel Advisors sold 403 MedAvail Holdings, Inc. Common Stock shares in Q3 2022, an estimated $23.1K.
Citadel Advisors first reported a position in MedAvail Holdings, Inc. Common Stock in Q4 2015 and held it in 11 quarters.
Citadel Advisors's MedAvail Holdings, Inc. Common Stock position peaked at $44K in Q4 2019.
32 funds tracked by Wall St. Rank held MedAvail Holdings, Inc. Common Stock as of Q3 2022.

Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.